These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14134684)
1. [LIMITATIONS OF USE AND HAZARDS OF FIBRINOLYTIC THERAPY WITH STREPTOKINASE]. OHLER WG Med Klin; 1964 Jan; 59():61-4. PubMed ID: 14134684 [No Abstract] [Full Text] [Related]
2. EFFICACY OF THROMBOLYTIC THERAPY WITH STREPTOKINASE USING A NEW ADMINISTRATION SCHEME. VERSTRAETE M; VERMYLEN J; DEVREKER R; AMERY A; VERMYLEN C Scand J Clin Lab Invest; 1964; 16():SUPPL 78:15-22. PubMed ID: 14199704 [No Abstract] [Full Text] [Related]
3. [On the dosage of streptokinase in fibrinolytic therapy]. STACHER A; BOEHNEL J Wien Klin Wochenschr; 1961 Sep; 73():665-8. PubMed ID: 13916043 [No Abstract] [Full Text] [Related]
4. [THROMBOLYTIC THERAPY. TRIAL TREATMENT WITH PURIFIED STREPTOKINASE]. MARCHAL G; SOULIE P; BILSKI PASQUIER G; ABASTADO M; CASTEL A; GOGLIN G; PROST RJ; SAMAMA M Arch Mal Coeur Vaiss; 1964 Jul; 57():753-72. PubMed ID: 14182459 [No Abstract] [Full Text] [Related]
6. [Methodological research on the control of fibrinolytic therapy with streptokinase]. CROLLE G; MARX R Rass Fisiopatol Clin Ter; 1962; 34():17-45. PubMed ID: 13882309 [No Abstract] [Full Text] [Related]
7. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
8. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT. AMERY A; VERMYLEN J; MAES H; VERSTRAETE M Acta Haematol; 1964 Feb; 31():103-5. PubMed ID: 14131781 [No Abstract] [Full Text] [Related]
9. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY. CLIFFTON EE Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024 [No Abstract] [Full Text] [Related]
10. Developments in fibrinolytic therapy for thrombo-embolic disease. SHERRY S; FLETCHER AP; ALKJAERSIG N Ann Intern Med; 1959 Mar; 50(3):560-70. PubMed ID: 13627713 [No Abstract] [Full Text] [Related]
11. Thrombolytic therapy. MCNICOL GP Proc R Soc Med; 1963 May; 56(5):414-8. PubMed ID: 13932243 [No Abstract] [Full Text] [Related]
12. [Laboratory control of thrombolytic therapy with streptokinase]. BALSTRUP F; BANG NU; INVERSEN K Ugeskr Laeger; 1962 Apr; 124():531-41. PubMed ID: 13864518 [No Abstract] [Full Text] [Related]
13. [LABORATORY CONTROL OF THROMBOLYTIC THERAPY]. OSTEN W Med Lab (Stuttg); 1964 Feb; 17():42-5. PubMed ID: 14151272 [No Abstract] [Full Text] [Related]
15. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT]. STOICHITA M Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194 [No Abstract] [Full Text] [Related]
16. [TRYPSIN-CHYMOTRYPSIN IN THE VASCULAR OCCLUSIVE PROCESSES]. MOSSO HE; PERGOLA F; MARCEILLAC E Prensa Med Argent; 1963 Apr; 50():1081-4. PubMed ID: 14089189 [No Abstract] [Full Text] [Related]
17. [ON THE PERFORMANCE OF THROMBOLYTIC TREATMENT WITH STREPTOKINASE]. WINCKELMANN G; HELMS M Med Klin; 1963 Sep; 58():1568-71. PubMed ID: 14050317 [No Abstract] [Full Text] [Related]
18. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY. HAWKEY C; HOWELL M J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462 [TBL] [Abstract][Full Text] [Related]
19. [Streptokinase and streptodornase; new fibrinolytic and liquafacient of purulent exudates]. ELIAS COSTA J Dia Med; 1953 Jan; 25(4):73-4. PubMed ID: 13033619 [No Abstract] [Full Text] [Related]